Prices of statin based hyperlipemic medicines to be reduced
Published: 2008-05-01 06:56:00
Updated: 2008-05-01 06:56:00
The Health Review Insurance Agency says health insurance prices of statin based hyperlipemic agents, such as Pfizer’s Lipitor, will be reduced as a result of evaluating the economic effectiveness of those medicines, except for simvastatin preparation.
For the reassessment and cutbacks of the d...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
